Cellebrite DI Ltd.
CLBT
$18.25
$0.975.61%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 20.12% | 15.72% | 13.47% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 20.12% | 15.72% | 13.47% | |
| Cost of Revenue | -- | 4.90% | -0.99% | 7.71% | |
| Gross Profit | -- | 23.63% | 19.70% | 14.80% | |
| SG&A Expenses | -- | 11.58% | 5.20% | 1.69% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 8.26% | 3.47% | 5.73% | |
| Operating Income | -- | 3,083.62% | 745.51% | 310.84% | |
| Income Before Tax | -- | -162.57% | -132.64% | -123.46% | |
| Income Tax Expenses | -- | 12,404.44% | 2,905.14% | -44.68% | |
| Earnings from Continuing Operations | -- | -167.13% | -135.85% | -127.44% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -167.13% | -135.85% | -127.44% | |
| EBIT | -- | 3,083.62% | 745.51% | 310.84% | |
| EBITDA | -- | 307.53% | 824.14% | 1,125.93% | |
| EPS Basic | -- | -169.54% | -138.55% | -129.66% | |
| Normalized Basic EPS | -- | -200.28% | -124.48% | -124.48% | |
| EPS Diluted | -- | -177.87% | -143.08% | -134.27% | |
| Normalized Diluted EPS | -- | -205.65% | -127.06% | -127.06% | |
| Average Basic Shares Outstanding | -- | 4.08% | 3.46% | 8.03% | |
| Average Diluted Shares Outstanding | -- | -0.12% | -1.14% | 1.30% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
